Literature DB >> 9334294

The structure of nitric oxide synthase oxygenase domain and inhibitor complexes.

B R Crane1, A S Arvai, R Gachhui, C Wu, D K Ghosh, E D Getzoff, D J Stuehr, J A Tainer.   

Abstract

The nitric oxide synthase oxygenase domain (NOSox) oxidizes arginine to synthesize the cellular signal and defensive cytotoxin nitric oxide (NO). Crystal structures determined for cytokine-inducible NOSox reveal an unusual fold and heme environment for stabilization of activated oxygen intermediates key for catalysis. A winged beta sheet engenders a curved alpha-beta domain resembling a baseball catcher's mitt with heme clasped in the palm. The location of exposed hydrophobic residues and the results of mutational analysis place the dimer interface adjacent to the heme-binding pocket. Juxtaposed hydrophobic O2- and polar L-arginine-binding sites occupied by imidazole and aminoguanidine, respectively, provide a template for designing dual-function inhibitors and imply substrate-assisted catalysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334294     DOI: 10.1126/science.278.5337.425

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  56 in total

Review 1.  Substrate-assisted catalysis: molecular basis and biological significance.

Authors:  W Dall'Acqua; P Carter
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

Review 2.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

3.  Pulsed ENDOR determination of the arginine location in the ferrous-NO form of neuronal NOS.

Authors:  Andrei V Astashkin; Bradley O Elmore; Li Chen; Weihong Fan; J Guy Guillemette; Changjian Feng
Journal:  J Phys Chem A       Date:  2012-06-15       Impact factor: 2.781

4.  Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design.

Authors:  Roman Fedorov; Ryan Vasan; Dipak K Ghosh; Ilme Schlichting
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

5.  Pulsed ENDOR determination of relative orientation of g-frame and molecular frame of imidazole-coordinated heme center of iNOS.

Authors:  Andrei V Astashkin; Weihong Fan; Bradley O Elmore; J Guy Guillemette; Changjian Feng
Journal:  J Phys Chem A       Date:  2011-08-26       Impact factor: 2.781

Review 6.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

7.  Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.

Authors:  C W Yang; C C Yu; Y C Ko; C C Huang
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Substrate-ligand interactions in Geobacillus stearothermophilus nitric oxide synthase.

Authors:  Mariam Kabir; Jawahar Sudhamsu; Brian R Crane; Syun-Ru Yeh; Denis L Rousseau
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

9.  Stabilization and characterization of a heme-oxy reaction intermediate in inducible nitric-oxide synthase.

Authors:  Jesús Tejero; Ashis Biswas; Zhi-Qiang Wang; Richard C Page; Mohammad Mahfuzul Haque; Craig Hemann; Jay L Zweier; Saurav Misra; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

Review 10.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.